CD8A and precursor B-cell acute lymphoblastic leukemia: Conversely, CD3 + CD8 + CD48 + cells were significantly increased in B-ALL patients compared to controls (98.5 ± 2% vs. 88.5 ± 7.1%, p < 0.0001).